HomeCompareSZLSF vs EPRT

SZLSF vs EPRT: Dividend Comparison 2026

SZLSF yields 39215.69% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SZLSF wins by $4.252735580217355e+22M in total portfolio value
10 years
SZLSF
SZLSF
● Live price
39215.69%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.252735580217355e+22M
Annual income
$42,315,093,309,418,040,000,000,000,000.00
Full SZLSF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — SZLSF vs EPRT

📍 SZLSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSZLSFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SZLSF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SZLSF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SZLSF
Annual income on $10K today (after 15% tax)
$3,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$35,967,829,313,005,333,000,000,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, SZLSF beats the other by $35,967,829,313,005,333,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SZLSF + EPRT for your $10,000?

SZLSF: 50%EPRT: 50%
100% EPRT50/50100% SZLSF
Portfolio after 10yr
$2.1263677901086776e+22M
Annual income
$21,157,546,654,709,020,000,000,000,000.00/yr
Blended yield
99.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

SZLSF
No analyst data
Altman Z
-336.3
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SZLSF buys
0
EPRT buys
0
No recent congressional trades found for SZLSF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSZLSFEPRT
Forward yield39215.69%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$4.252735580217355e+22M$63.4K
Annual income after 10y$42,315,093,309,418,040,000,000,000,000.00$12,840.73
Total dividends collected$4.251340866571809e+22M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: SZLSF vs EPRT ($10,000, DRIP)

YearSZLSF PortfolioSZLSF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$3,932,269$3,921,568.63$11,205$505.18+$3.92MSZLSF
2$1,445,390,825$1,441,183,297.58$12,672$682.46+$1445.38MSZLSF
3$496,629,048,205$495,082,480,022.34$14,490$930.48+$496629.03MSZLSF
4$159,510,701,964,776$158,979,308,883,196.16$16,786$1,282.69+$159510701.95MSZLSF
5$47,892,225,784,148,210$47,721,549,333,045,900.00$19,753$1,791.56+$47892225784.13MSZLSF
6$13,442,027,069,357,296,000$13,390,782,387,768,257,000.00$23,677$2,541.64+$13442027069357.27MSZLSF
7$3,526,928,149,355,307,700,000$3,512,545,180,391,095,400,000.00$29,008$3,672.99+$3526928149355307.50MSZLSF
8$865,104,634,553,737,800,000,000$861,330,821,433,927,700,000,000.00$36,463$5,425.08+$865104634553737856.00MSZLSF
9$198,376,161,453,751,100,000,000,000$197,450,499,494,778,630,000,000,000.00$47,238$8,221.57+$198376161453751107584.00MSZLSF
10$42,527,355,802,173,560,000,000,000,000$42,315,093,309,418,040,000,000,000,000.00$63,385$12,840.73+$4.252735580217355e+22MSZLSF

SZLSF vs EPRT: Complete Analysis 2026

SZLSFStock

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is Aristotle, a multi-cancer panel test for simultaneously screening for various cancers from a single sample of blood with high sensitivity and specificity for each cancer. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; COVID polymerase chain reaction testing and blood test analysis; Prostate Health Index, a screening test for prostate cancer; and BreastSentry, a test to determine a woman's risk for developing breast cancer. The company was founded in 1998 and is headquartered in Richmond Hill, Canada.

Full SZLSF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this SZLSF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SZLSF vs SCHDSZLSF vs JEPISZLSF vs OSZLSF vs KOSZLSF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.